News

Photo
06.10.2025 • NewsChemistry

Syensqo Announces CEO Transition

Syensqo has announced that Ilham Kadri will step down as CEO on January 1, 2026, with Mike Radossich, current President of Performance & Care, set to assume the role and lead the company into its next growth phase.

Photo
01.10.2025 • News

Arkema Opens Battery Dry Coating Laboratory

Arkema has inaugurated a new laboratory in Normandy dedicated to dry coating processes for battery electrodes, aiming to advance sustainable manufacturing by reducing energy use and developing new battery solutions.

Photo
19.09.2025 • NewsPharma

Roche to Acquire 89Bio in $3.5 Billion Deal

Acquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination development.

13756 more News

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.